Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

910 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
Foldi J, Silber A, Reisenbichler E, Singh K, Fischbach N, Persico J, Adelson K, Katoch A, Horowitz N, Lannin D, Chagpar A, Park T, Marczyk M, Frederick C, Burrello T, Ibrahim E, Qing T, Bai Y, Blenman K, Rimm DL, Pusztai L. Foldi J, et al. Among authors: ibrahim e. NPJ Breast Cancer. 2022 Feb 3;8(1):17. doi: 10.1038/s41523-022-00392-3. NPJ Breast Cancer. 2022. PMID: 35115541 Free PMC article. No abstract available.
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
Foldi J, Silber A, Reisenbichler E, Singh K, Fischbach N, Persico J, Adelson K, Katoch A, Horowitz N, Lannin D, Chagpar A, Park T, Marczyk M, Frederick C, Burrello T, Ibrahim E, Qing T, Bai Y, Blenman K, Rimm DL, Pusztai L. Foldi J, et al. Among authors: ibrahim e. NPJ Breast Cancer. 2021 Feb 8;7(1):9. doi: 10.1038/s41523-021-00219-7. NPJ Breast Cancer. 2021. PMID: 33558513 Free PMC article.
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.
Marczyk M, Qing T, O'Meara T, Yagahoobi V, Pelekanou V, Bai Y, Reisenbichler E, Cole KS, Li X, Gunasekharan V, Ibrahim E, Fanucci K, Wei W, Rimm DL, Pusztai L, Blenman KRM. Marczyk M, et al. Among authors: ibrahim e. NPJ Breast Cancer. 2022 Jul 22;8(1):88. doi: 10.1038/s41523-022-00449-3. NPJ Breast Cancer. 2022. PMID: 35869114 Free PMC article.
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
Blenman KRM, Marczyk M, Karn T, Qing T, Li X, Gunasekharan V, Yaghoobi V, Bai Y, Ibrahim EY, Park T, Silber A, Wolf DM, Reisenbichler E, Denkert C, Sinn BV, Rozenblit M, Foldi J, Rimm DL, Loibl S, Pusztai L. Blenman KRM, et al. Among authors: ibrahim ey. Clin Cancer Res. 2022 Jun 13;28(12):2587-2597. doi: 10.1158/1078-0432.CCR-21-3215. Clin Cancer Res. 2022. PMID: 35377948 Free PMC article. Clinical Trial.
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
Yaghoobi V, Moutafi M, Aung TN, Pelekanou V, Yaghoubi S, Blenman K, Ibrahim E, Vathiotis IA, Shafi S, Sharma A, O'Meara T, Fernandez AI, Pusztai L, Rimm DL. Yaghoobi V, et al. Among authors: ibrahim e. Breast Cancer Res. 2021 Dec 14;23(1):113. doi: 10.1186/s13058-021-01493-w. Breast Cancer Res. 2021. PMID: 34906209 Free PMC article.
The Impact of Mutations in Wolframin on Psychiatric Disorders.
Munshani S, Ibrahim EY, Domenicano I, Ehrlich BE. Munshani S, et al. Among authors: ibrahim ey. Front Pediatr. 2021 Oct 21;9:718132. doi: 10.3389/fped.2021.718132. eCollection 2021. Front Pediatr. 2021. PMID: 34746052 Free PMC article.
910 results